{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:51:36Z","timestamp":1789829496174,"version":"4.0.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T00:00:00Z","timestamp":1574467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T00:00:00Z","timestamp":1574467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s10875-019-00720-6","type":"journal-article","created":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T17:02:25Z","timestamp":1574528545000},"page":"165-178","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Mutual alteration of NOD2-associated Blau syndrome and IFN\u03b3R1 deficiency"],"prefix":"10.1007","volume":"40","author":[{"given":"Zuzana","family":"Parackova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marketa","family":"Bloomfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Vrabcova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Zentsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Klocperk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Milota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Svaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Laurent","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacinta","family":"Bustamante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Fronkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sediva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,23]]},"reference":[{"key":"720_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1546-0096-12-33","volume":"12","author":"CH Wouters","year":"2014","unstructured":"Wouters CH, Maes A, Foley KP, Bertin J, Rose CD. Blau syndrome, the prototypic auto-inflammatory granulomatous disease. Pediatr Rheumatol Online J. 2014;12:33. https:\/\/doi.org\/10.1186\/1546-0096-12-33.","journal-title":"Pediatr Rheumatol Online J"},{"key":"720_CR2","doi-asserted-by":"publisher","unstructured":"Rose CD, Pans S, Casteels I, Anton J, Bader-Meunier B, Brissaud P, et al. Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes. Rheumatology. 2015;54:1008\u201316. https:\/\/doi.org\/10.1093\/rheumatology\/keu437.","DOI":"10.1093\/rheumatology\/keu437"},{"key":"720_CR3","doi-asserted-by":"publisher","unstructured":"Kanazawa N, Okafuji I, Kambe N, Nishikomori R, Nakata-Hizume M, Nagai S, et al. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood. 2005;105:1195\u20137. https:\/\/doi.org\/10.1182\/blood-2004-07-2972.","DOI":"10.1182\/blood-2004-07-2972"},{"key":"720_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nri3565","volume":"14","author":"DJ Philpott","year":"2014","unstructured":"Philpott DJ, Sorbara MT, Robertson SJ, Croitoru K, Girardin SE. NOD proteins: regulators of inflammation in health and disease. Nat Rev Immunol. 2014;14:9\u201323. https:\/\/doi.org\/10.1038\/nri3565.","journal-title":"Nat Rev Immunol"},{"key":"720_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2147\/JIR.S137606","volume":"11","author":"A Negroni","year":"2018","unstructured":"Negroni A, Pierdomenico M, Cucchiara S, Stronati L. NOD2 and inflammation: current insights. J Inflamm Res. 2018;11:49\u201360. https:\/\/doi.org\/10.2147\/JIR.S137606.","journal-title":"J Inflamm Res"},{"key":"720_CR6","doi-asserted-by":"publisher","unstructured":"Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem. 2003;278:8869\u201372. https:\/\/doi.org\/10.1074\/jbc.C200651200.","DOI":"10.1074\/jbc.C200651200"},{"key":"720_CR7","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1189\/jlb.3A1114-557R","volume":"97","author":"MB Landes","year":"2015","unstructured":"Landes MB, Rajaram MVS, Nguyen H, Schlesinger LS. Role for NOD2 in Mycobacterium tuberculosis -induced iNOS expression and NO production in human macrophages. J Leukoc Biol. 2015;97:1111\u20139. https:\/\/doi.org\/10.1189\/jlb.3A1114-557R.","journal-title":"J Leukoc Biol"},{"key":"720_CR8","doi-asserted-by":"publisher","unstructured":"Brooks MN, Rajaram MVS, Azad AK, Amer AO, Valdivia-Arenas MA, Park J-H, et al. NOD2 controls the nature of the inflammatory response and subsequent fate of Mycobacterium tuberculosis and M. bovis BCG in human macrophages. Cell Microbiol. 2011;13:402\u201318. https:\/\/doi.org\/10.1111\/j.1462-5822.2010.01544.x.","DOI":"10.1111\/j.1462-5822.2010.01544.x"},{"key":"720_CR9","doi-asserted-by":"publisher","unstructured":"Kleinnijenhuis J, Quintin J, Preijers F, Joosten LAB, Ifrim DC, Saeed S, et al. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci. 2012;109:17537\u201342. https:\/\/doi.org\/10.1073\/pnas.1202870109.","DOI":"10.1073\/pnas.1202870109"},{"key":"720_CR10","doi-asserted-by":"publisher","unstructured":"Miceli-Richard C, Lesage S, Rybojad M, Prieur A-M, Manouvrier-Hanu S, H\u00e4fner R, et al. CARD15 mutations in Blau syndrome. Nat Genet. 2001;29:19\u201320. https:\/\/doi.org\/10.1038\/ng720.","DOI":"10.1038\/ng720"},{"key":"720_CR11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/BOR.0b013e328349c430","volume":"23","author":"CD Rose","year":"2011","unstructured":"Rose CD, Martin TM, Wouters CH. Blau syndrome revisited. Curr Opin Rheumatol. 2011;23:411\u20138. https:\/\/doi.org\/10.1097\/BOR.0b013e328349c430.","journal-title":"Curr Opin Rheumatol"},{"key":"720_CR12","doi-asserted-by":"publisher","unstructured":"Ebrahimiadib N, Samra KA, Domina AM, Stiles ER, Ewer R, Bocian CP, et al. A novel NOD2-associated mutation and variant Blau syndrome: phenotype and molecular analysis. Ocul Immunol Inflamm. 2018;26:57\u201364. https:\/\/doi.org\/10.1080\/09273948.2016.1185529.","DOI":"10.1080\/09273948.2016.1185529"},{"key":"720_CR13","doi-asserted-by":"publisher","unstructured":"Martin TM, Zhang Z, Kurz P, Ros\u00e9 CD, Chen H, Lu H, et al. The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity. Arthritis Rheum. 2009;60:611\u20138. https:\/\/doi.org\/10.1002\/art.24222.","DOI":"10.1002\/art.24222"},{"key":"720_CR14","doi-asserted-by":"publisher","unstructured":"Son S, Lee J, Woo C-W, Kim I, Kye Y, Lee K, et al. Altered cytokine profiles of mononuclear cells after stimulation in a patient with Blau syndrome. Rheumatol Int. 2010;30:1121\u20134. https:\/\/doi.org\/10.1007\/s00296-009-1342-4.","DOI":"10.1007\/s00296-009-1342-4"},{"key":"720_CR15","doi-asserted-by":"publisher","unstructured":"Dugan J, Griffiths E, Snow P, Rosenzweig H, Lee E, Brown B, et al. Blau syndrome\u2013associated Nod2 mutation alters expression of full-length NOD2 and limits responses to muramyl dipeptide in knock-in mice. J Immunol. 2015;194:349\u201357. https:\/\/doi.org\/10.4049\/jimmunol.1402330.","DOI":"10.4049\/jimmunol.1402330"},{"key":"720_CR16","doi-asserted-by":"publisher","unstructured":"Rosenstiel P, Fantini M, Br\u00e4utigam K, K\u00fchbacher T, Waetzig GH, Seegert D, et al. TNF-\u03b1 and IFN-\u03b3 regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology. 2003;124:1001\u20139. https:\/\/doi.org\/10.1053\/gast.2003.50157.","DOI":"10.1053\/gast.2003.50157"},{"key":"720_CR17","doi-asserted-by":"publisher","unstructured":"Takada S, Kambe N, Kawasaki Y, Niwa A, Honda-Ozaki F, Kobayashi K, et al. Pluripotent stem cell models of Blau syndrome reveal an IFN-\u03b3\u2013dependent inflammatory response in macrophages. J Allergy Clin Immunol. 2018;141:339\u2013349.e11. https:\/\/doi.org\/10.1016\/j.jaci.2017.04.013.","DOI":"10.1016\/j.jaci.2017.04.013"},{"key":"720_CR18","doi-asserted-by":"publisher","unstructured":"Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, et al. A mutation in the interferon-\u03b3 \u2013receptor gene and susceptibility to mycobacterial infection. N Engl J Med. 1996;335:1941\u20139. https:\/\/doi.org\/10.1056\/NEJM199612263352602.","DOI":"10.1056\/NEJM199612263352602"},{"key":"720_CR19","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0022-3476(99)70050-8","volume":"135","author":"JL Casanova","year":"1999","unstructured":"Casanova JL, Ochs H. Interferon-gamma receptor deficiency: an expanding clinical phenotype? J Pediatr. 1999;135:543\u20135. https:\/\/doi.org\/10.1016\/S0022-3476(99)70050-8.","journal-title":"J Pediatr"},{"key":"720_CR20","doi-asserted-by":"publisher","unstructured":"Jouanguy E, Lamhamedi-Cherradi S, Altare F, Fondan\u00e8che MC, Tuerlinckx D, Blanche S, et al. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Gu\u00e9rin infection and a sibling with clinical tuberculosis. J Clin Invest. 1997;100:2658\u201364. https:\/\/doi.org\/10.1172\/JCI119810.","DOI":"10.1172\/JCI119810"},{"key":"720_CR21","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","volume":"26","author":"J Bustamante","year":"2014","unstructured":"Bustamante J, Boisson-Dupuis S, Abel L, Casanova J-L. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-\u03b3 immunity. Semin Immunol. 2014;26:454\u201370. https:\/\/doi.org\/10.1016\/j.smim.2014.09.008.","journal-title":"Semin Immunol"},{"key":"720_CR22","doi-asserted-by":"publisher","unstructured":"Rosain J, Kong X-F, Martinez-Barricarte R, Oleaga-Quintas C, Ramirez-Alejo N, Markle J, et al. Mendelian susceptibility to mycobacterial disease: 2014-2018 update. Immunol Cell Biol. 2018. https:\/\/doi.org\/10.1111\/imcb.12210.","DOI":"10.1111\/imcb.12210"},{"key":"720_CR23","doi-asserted-by":"publisher","unstructured":"Oleaga-Quintas C, Deswarte C, Moncada-V\u00e9lez M, Metin A, Krishna Rao I, Kan\u0131k-Y\u00fcksek S, et al. A purely quantitative form of partial recessive IFN-\u03b3R2 deficiency caused by mutations of the initiation or second codon. Hum Mol Genet. 2018;27:3919\u201335. https:\/\/doi.org\/10.1093\/hmg\/ddy275.","DOI":"10.1093\/hmg\/ddy275"},{"key":"720_CR24","doi-asserted-by":"publisher","unstructured":"Boisson-Dupuis S, Ramirez-Alejo N, Li Z, Patin E, Rao G, Kerner G, et al. Tuberculosis and impaired IL-23\u2013dependent IFN-\u03b3 immunity in humans homozygous for a common TYK2 missense variant. Sci Immunol. 2018;3:eaau8714. https:\/\/doi.org\/10.1126\/sciimmunol.aau8714.","DOI":"10.1126\/sciimmunol.aau8714"},{"key":"720_CR25","doi-asserted-by":"publisher","unstructured":"Mart\u00ednez-Barricarte R, Markle JG, Ma CS, Deenick EK, Ram\u00edrez-Alejo N, Mele F, et al. Human IFN-\u03b3 immunity to mycobacteria is governed by both IL-12 and IL-23. Sci Immunol. 2018;3:eaau6759. https:\/\/doi.org\/10.1126\/sciimmunol.aau6759.","DOI":"10.1126\/sciimmunol.aau6759"},{"key":"720_CR26","doi-asserted-by":"publisher","unstructured":"Kong X-F, Martinez-Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick EK, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol. 2018;19:973\u201385. https:\/\/doi.org\/10.1038\/s41590-018-0178-z.","DOI":"10.1038\/s41590-018-0178-z"},{"key":"720_CR27","doi-asserted-by":"publisher","unstructured":"Filipe-Santos O, Bustamante J, Chapgier A, Vogt G, de Beaucoudrey L, Feinberg J, et al. Inborn errors of IL-12\/23- and IFN-\u03b3-mediated immunity: molecular, cellular, and clinical features. Semin Immunol. 2006;18:347\u201361. https:\/\/doi.org\/10.1016\/j.smim.2006.07.010.","DOI":"10.1016\/j.smim.2006.07.010"},{"key":"720_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.0105-2896.2005.00227.x","volume":"203","author":"SD Rosenzweig","year":"2005","unstructured":"Rosenzweig SD, Holland SM. Defects in the interferon-gamma and interleukin-12 pathways. Immunol Rev. 2005;203:38\u201347. https:\/\/doi.org\/10.1111\/j.0105-2896.2005.00227.x.","journal-title":"Immunol Rev"},{"key":"720_CR29","doi-asserted-by":"publisher","unstructured":"Casanova J-L, Jouanguy E, Lamhamedi-Cherradi S, Lammas D, Dorman SE, Fondan\u00e8che M-C, et al. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet. 1999;21:370\u20138. https:\/\/doi.org\/10.1038\/7701.","DOI":"10.1038\/7701"},{"key":"720_CR30","doi-asserted-by":"publisher","unstructured":"Dorman SE, Picard C, Lammas D, Heyne K, van Dissel JT, Baretto R, et al. Clinical features of dominant and recessive interferon \u03b3 receptor 1 deficiencies. Lancet. 2004;364:2113\u201321. https:\/\/doi.org\/10.1016\/S0140-6736(04)17552-1.","DOI":"10.1016\/S0140-6736(04)17552-1"},{"key":"720_CR31","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754\u201360. https:\/\/doi.org\/10.1093\/bioinformatics\/btp324.","journal-title":"Bioinformatics"},{"key":"720_CR32","doi-asserted-by":"publisher","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. 1000 genome project data processing subgroup. The Sequence Alignment\/Map format and SAMtools. Bioinformatics. 2009;25:2078\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btp352.","DOI":"10.1093\/bioinformatics\/btp352"},{"key":"720_CR33","doi-asserted-by":"publisher","unstructured":"Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L, et al. VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 2012;22:568\u201376. https:\/\/doi.org\/10.1101\/gr.129684.111.","DOI":"10.1101\/gr.129684.111"},{"key":"720_CR34","doi-asserted-by":"publisher","unstructured":"Cingolani P, Patel VM, Coon M, Nguyen T, Land SJ, Ruden DM, et al. Using drosophila melanogaster as a model for genotoxic chemical mutational studies with a new program. SnpSift Front Genet. 2012;3:35. https:\/\/doi.org\/10.3389\/fgene.2012.00035.","DOI":"10.3389\/fgene.2012.00035"},{"key":"720_CR35","doi-asserted-by":"publisher","unstructured":"Janssen CEI, Rose CD, De Hertogh G, Martin TM, Bader Meunier B, Cimaz R, et al. Morphologic and immunohistochemical characterization of granulomas in the nucleotide oligomerization domain 2\u2013related disorders Blau syndrome and Crohn disease. J Allergy Clin Immunol. 2012;129:1076\u201384. https:\/\/doi.org\/10.1016\/j.jaci.2012.02.004.","DOI":"10.1016\/j.jaci.2012.02.004"},{"key":"720_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/imr.12721","volume":"287","author":"N Mitsuiki","year":"2019","unstructured":"Mitsuiki N, Schwab C, Grimbacher B. What did we learn from CTLA-4 insufficiency on the human immune system? Immunol Rev. 2019;287:33\u201349. https:\/\/doi.org\/10.1111\/imr.12721.","journal-title":"Immunol Rev"},{"key":"720_CR37","doi-asserted-by":"publisher","unstructured":"Schwab C, Gabrysch A, Olbrich P, Pati\u00f1o V, Warnatz K, Wolff D, et al. Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4\u2013insufficient subjects. J Allergy Clin Immunol. 2018;142:1932\u201346. https:\/\/doi.org\/10.1016\/j.jaci.2018.02.055.","DOI":"10.1016\/j.jaci.2018.02.055"},{"key":"720_CR38","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.1172\/JCI72476","volume":"123","author":"A La Cava","year":"2013","unstructured":"La Cava A. Common variable immunodeficiency: two mutations are better than one. J Clin Invest. 2013;123:4142\u20133. https:\/\/doi.org\/10.1172\/JCI72476.","journal-title":"J Clin Invest"},{"key":"720_CR39","doi-asserted-by":"publisher","unstructured":"Zhang S-Y, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science (80- ). 2007, 317:1522\u20137. https:\/\/doi.org\/10.1126\/science.1139522.","DOI":"10.1126\/science.1139522"},{"key":"720_CR40","doi-asserted-by":"publisher","unstructured":"Chapgier A, Boisson-Dupuis S, Jouanguy E, Vogt G, Feinberg J, Prochnicka-Chalufour A, et al. Novel STAT1 Alleles in otherwise healthy patients with mycobacterial disease. PLoS Genet. 2006;2:e131. https:\/\/doi.org\/10.1371\/journal.pgen.0020131.","DOI":"10.1371\/journal.pgen.0020131"},{"key":"720_CR41","doi-asserted-by":"publisher","unstructured":"Takeda K, Kawai T, Nakazawa Y, Komuro H, Shoji K, Morita K, et al. Augmentation of antitubercular therapy with IFN\u03b3 in a patient with dominant partial IFN\u03b3 receptor 1 deficiency. Clin Immunol. 2014;151:25\u20138. https:\/\/doi.org\/10.1016\/j.clim.2014.01.004.","DOI":"10.1016\/j.clim.2014.01.004"},{"key":"720_CR42","doi-asserted-by":"publisher","unstructured":"Saulsbury FT, Wouters CH, Martin TM, Austin CR, Doyle TM, Goodwin KA, et al. Incomplete penetrance of the NOD2 E383K substitution among members of a pediatric granulomatous arthritis pedigree. Arthritis Rheum. 2009;60:1804\u20136. https:\/\/doi.org\/10.1002\/art.24532.","DOI":"10.1002\/art.24532"},{"key":"720_CR43","doi-asserted-by":"publisher","unstructured":"Ros\u00e9 CD, Ar\u00f3stegui JI, Martin TM, Espada G, Scalzi L, Yag\u00fce J, et al. NOD2-associated pediatric granulomatous arthritis, an expanding phenotype: study of an international registry and a national cohort in Spain. Arthritis Rheum. 2009;60:1797\u2013803. https:\/\/doi.org\/10.1002\/art.24533.","DOI":"10.1002\/art.24533"},{"key":"720_CR44","doi-asserted-by":"publisher","first-page":"e385","DOI":"10.1111\/pde.12908","volume":"33","author":"J Harada","year":"2016","unstructured":"Harada J, Nakajima T, Kanazawa N. A case of Blau syndrome with NOD2 E383K mutation. Pediatr Dermatol. 2016;33:e385\u20137. https:\/\/doi.org\/10.1111\/pde.12908.","journal-title":"Pediatr Dermatol"},{"key":"720_CR45","doi-asserted-by":"publisher","unstructured":"Galozzi P, Negm O, Greco E, Alkhattabi N, Gava A, Sfriso P, et al. Ex vivo and in vitro production of pro-inflammatory cytokines in Blau syndrome. Reumatismo. 2015;66:277\u201384. https:\/\/doi.org\/10.4081\/reumatismo.2014.772.","DOI":"10.4081\/reumatismo.2014.772"},{"key":"720_CR46","doi-asserted-by":"publisher","first-page":"E48","DOI":"10.1542\/PEDS.107.4.E48","volume":"107","author":"C Fieschi","year":"2001","unstructured":"Fieschi C, Dupuis S, Picard C, Smith CI, Holland SM, Casanova JL. High levels of interferon gamma in the plasma of children with complete interferon gamma receptor deficiency. Pediatrics. 2001;107:E48. https:\/\/doi.org\/10.1542\/PEDS.107.4.E48.","journal-title":"Pediatrics"},{"key":"720_CR47","doi-asserted-by":"publisher","unstructured":"J-Fran EMILE, PATEY N, Fr ALTARE, LAMHAMEDI S, JOUANGUY E, Fran BOMAN, et al. MOUSNIER J-Fran, et al. Correlation of granuloma structure with clinical outcome defines two types of idiopathic disseminated BCG infection. J Pathol. 1997;181:25\u201330. https:\/\/doi.org\/10.1002\/(SICI)1096-9896(199701)181:1<25::AID-PATH747>3.0.CO;2-Z.","DOI":"10.1002\/(SICI)1096-9896(199701)181:1<25::AID-PATH747>3.0.CO;2-Z"},{"key":"720_CR48","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1159\/000341472","volume":"30","author":"J Xie","year":"2012","unstructured":"Xie J, Deng W. NOD2 signaling and role in pathogenic mycobacterium recognition, infection and immunity. Cell Physiol Biochem. 2012;30:953\u201363. https:\/\/doi.org\/10.1159\/000341472.","journal-title":"Cell Physiol Biochem"},{"key":"720_CR49","doi-asserted-by":"publisher","unstructured":"Ferwerda G, Girardin SE, Kullberg B-J, Le Bourhis L, de Jong DJ, Langenberg DML, et al. NOD2 and toll-like receptors are nonredundant recognition systems of mycobacterium tuberculosis. PLoS Pathog. 2005;1:e34. https:\/\/doi.org\/10.1371\/journal.ppat.0010034.","DOI":"10.1371\/journal.ppat.0010034"},{"key":"720_CR50","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1067\/mjd.2003.158","volume":"48","author":"GEN Osborne","year":"2003","unstructured":"Osborne GEN, Mallon E, Mayou SC. Juvenile sarcoidosis after BCG vaccination. J Am Acad Dermatol. 2003;48:S99\u2013S102. https:\/\/doi.org\/10.1067\/mjd.2003.158.","journal-title":"J Am Acad Dermatol"},{"key":"720_CR51","doi-asserted-by":"publisher","unstructured":"Okafuji I, Nishikomori R, Kanazawa N, Kambe N, Fujisawa A, Yamazaki S, et al. Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis. Arthritis Rheum. 2009;60:242\u201350. https:\/\/doi.org\/10.1002\/art.24134.","DOI":"10.1002\/art.24134"},{"key":"720_CR52","doi-asserted-by":"publisher","unstructured":"Sakai H, Ito S, Nishikomori R, Takaoka Y, Kawai T, Saito M, et al. A case of early-onset sarcoidosis with a six-base deletion in the NOD2 gene. Rheumatology. 2010;49:194\u20136. https:\/\/doi.org\/10.1093\/rheumatology\/kep315.","DOI":"10.1093\/rheumatology\/kep315"},{"key":"720_CR53","doi-asserted-by":"publisher","unstructured":"Black GF, Weir RE, Floyd S, Bliss L, Warndorff DK, Crampin AC, et al. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet. 2002;359:1393\u2013401. https:\/\/doi.org\/10.1016\/S0140-6736(02)08353-8.","DOI":"10.1016\/S0140-6736(02)08353-8"},{"key":"720_CR54","doi-asserted-by":"publisher","unstructured":"\u00c7akan M, Keskindemirci G, Aydo\u011fmu\u015f \u00c7, Ak\u0131 H, Hatipo\u011flu N, K\u0131yak A, et al. Coexistence of early onset sarcoidosis and partial interferon-\u03b3 receptor 1 deficiency. Turk J Pediatr. 2016;58:545\u20139. https:\/\/doi.org\/10.24953\/turkjped.2016.05.015.","DOI":"10.24953\/turkjped.2016.05.015"},{"key":"720_CR55","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1182\/blood.V78.11.2918.2918","volume":"78","author":"JI Henter","year":"1991","unstructured":"Henter JI, Elinder G, S\u00f6der O, Hansson M, Andersson B, Andersson U. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood. 1991;78:2918\u201322 Available at: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1954380 [Accessed February 19, 2019].","journal-title":"Blood"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-019-00720-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-019-00720-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-019-00720-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T21:01:49Z","timestamp":1659042109000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-019-00720-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,23]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["720"],"URL":"https:\/\/doi.org\/10.1007\/s10875-019-00720-6","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,23]]},"assertion":[{"value":"11 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was carried out in accordance with the recommendation of the Ethical Committee of the 2nd Faculty of Medicine, Charles University, in Prague and University Hospital in Motol, Czech Republic. The protocol was approved by the Ethical Committee and all subjects gave informed consent in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}]}}